Cellecta, Inc., a spin-off of System Biosciences (SBI), was founded in April of 2006 by one of the chief scientists from Clontech Laboratories and SBI. Our mission is to develop and market genome-wide high throughput screening technologies and research tools for the discovery of new biologicals, drugs, and drug targets.

Cellecta is headed by an experienced management and product development team with a good product development track record, a network of outside scientific collaborators, and prior experience in start-up company operations. Located in Mountain View in the heart of Silicon Valley, the company resides in the "Biotech Bay" area near some of the most well-known research biotech companies and life science institutes including Affymetrix, Genentech, Stanford University, and the University of California, San Francisco.

Although a small private company, Cellecta is connected to a large network of collaborators, consultants, and colleagues, vastly improving its knowledge base in the research field. Cellecta has partnered with a multitude of scientists and institutions, including the Roswell Park Cancer Institute, Fred Hutchinson Cancer Research Center (FHCRC), The Scripps Research Institute (TSRI), Cleveland Biolabs, Harvard School of Public Health, and Tufts University. If you are interested in collaborating or investing in Cellecta, please contact us at collaborate@cellecta.com or invest@cellecta.com.

^ Back to top

Home | About Us | Contact Us | Register | Privacy Policy

Copyright © 2008, Cellecta, Inc. All rights reserved.

NOTE: This site is best viewed with Mozilla 2.0+, IE 7.0, or Netscape 8.0+